Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
AGIOAgios Pharmaceuticals	$2.06bn	n/a	n/a
AMLXAmylyx Pharmaceuticals	$2.03bn	n/a	n/a
CAPRCapricor Therapeutics	$2.01bn	n/a	n/a
RXRXRecursion Pharmaceuticals	$1.99bn	n/a	n/a
SIONSionna Therapeutics	$1.96bn	n/a	n/a
TRVITrevi Therapeutics	$1.96bn	n/a	n/a
ANABAnaptysBio	$1.94bn	n/a	n/a
ANABVAnaptysBio	$1.94bn	n/a	n/a
TYRATyra Biosciences	$1.92bn	n/a	n/a
RAPPRapport Therapeutics	$1.90bn	n/a	n/a
PHVSPharvaris NV	$1.87bn	n/a	n/a
BLUBELLUS Health	CA$2.47bn	n/a	n/a
PVLAPalvella Therapeutics	$1.86bn	n/a	n/a
TSHATaysha Gene Therapies	$1.85bn	n/a	n/a
FUSNFusion Pharmaceuticals	$1.83bn	n/a	n/a
NRIXNurix Therapeutics	$1.81bn	n/a	n/a
INBXInhibrx	$1.79bn	n/a	n/a
NUVBNuvation Bio	$1.77bn	n/a	n/a
NTLAIntellia Therapeutics	$1.77bn	n/a	n/a
AMAMAmbrx Biopharma	$1.76bn	n/a	n/a